Bruntál, Czechia

Miloš Mikoška

This inventor holds 1 USPTO granted patent. Top assignee: Vuab Pharma A.s.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miloš Mikoška. Retrieved from https://idiyas.com/inventor/miloš-mikoška

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Miloš Mikoška

Introduction

Miloš Mikoška is a notable inventor based in Bruntál, Czech Republic. He has made significant strides in the field of pharmaceuticals, particularly in developing new treatments for cancer. His work focuses on enhancing the efficacy of platinum (IV) complexes, which are crucial in the fight against various tumor diseases.

Latest Patents

Mikoška holds a patent for "Platinum IV complexes with substantially increased antitumor efficacy." This invention relates to new platinum (IV) complexes that demonstrate significantly improved antitumor properties. The patent also covers a process for preparing these complexes, a pharmaceutical composition, and a final dosage form for oral administration. The use of these new platinum (IV) complexes is particularly aimed at treating challenging cancers, such as pancreatic cancer, through oral administration.

Career Highlights

Miloš Mikoška is associated with Vuab Pharma A.S., where he continues to contribute to innovative pharmaceutical solutions. His dedication to research and development has positioned him as a key figure in the advancement of cancer treatments.

Collaborations

Mikoška has collaborated with notable colleagues, including Vladimír Kysilka and Jan Mengler. Their combined expertise enhances the research and development efforts at Vuab Pharma A.S.

Conclusion

Miloš Mikoška's contributions to the field of pharmaceuticals, particularly through his patent on platinum (IV) complexes, highlight his commitment to improving cancer treatment options. His work continues to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…